RHIGF-I administration increases in vivo peripheral insulin sensitivity in adults with type 1 diabetes mellitus

1998 ◽  
Vol 8 (4) ◽  
pp. 315
Author(s):  
PV Carroll ◽  
ER Christ ◽  
I Gowrie ◽  
R Hovorka ◽  
DL Russell-Jones ◽  
...  
2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Rongze Wang ◽  
Yuanxu Zhang ◽  
Fujun Jin ◽  
Gongchen Li ◽  
Yao Sun ◽  
...  

Abstract Type 1 diabetes mellitus (T1DM) is an autoimmune insulin-dependent disease associated with destructive bone homeostasis. Accumulating evidence has proven that miRNAs are widely involved in the regulation of bone homeostasis. However, whether miRNAs also regulate osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in T1DM mice is under exploration. In this study, miRNA microarray was utilized to screen the differentially expressed miRNAs, which uncovered that miR-214-3p potentially inhibited BMSCs osteogenic differentiation in T1DM mice. We found that high glucose suppressed BMSCs osteogenic differentiation with significant elevation of the miR-214-3p expression. Further study found that the osteogenic differentiation of BMSCs was inhibited by AgomiR-214-3p while enhanced by AntagomiR-214-3p in BMSCs supplemented with high glucose. Moreover, we found that miR-214-3p knockout T1DM mice were resistant to high-glucose-induced bone loss. These results provide a novel insight into an inhibitory role of high-glucose-induced miR-214-3p in BMSCs osteogenic differentiation both in vitro and in vivo. Molecular studies revealed that miR-214-3p inhibits BMSCs osteogenic differentiation by targeting the 3′-UTR of β-catenin, which was further corroborated in human bone specimens and BMSCs of T1DM patients. Taken together, our study discovered that miR-214-3p is a pivotal regulator of BMSCs osteogenic differentiation in T1DM mice. Our findings also suggest that miR-214-3p could be a potential target in the treatment of bone disorders in patients with T1DM.


Circulation ◽  
2018 ◽  
Vol 138 (25) ◽  
pp. 2895-2907 ◽  
Author(s):  
Petter Bjornstad ◽  
Michal Schäfer ◽  
Uyen Truong ◽  
Melanie Cree-Green ◽  
Laura Pyle ◽  
...  

1989 ◽  
Vol 52 (3) ◽  
pp. 406-413 ◽  
Author(s):  
Liisa Räsänen ◽  
H. Hyöty ◽  
Maili Lehto ◽  
O.-P. Kallioniemi ◽  
Tuula Huupponen ◽  
...  

2017 ◽  
Vol 139 (2) ◽  
pp. AB15
Author(s):  
Laise Cedraz Pinto ◽  
Ana Tereza Cerqueira-lima ◽  
Samara dos Santos Suzart ◽  
Raiane Souza ◽  
Bruna Tosta ◽  
...  

2015 ◽  
Vol 173 (1) ◽  
pp. 101-109 ◽  
Author(s):  
Esther Donga ◽  
Olaf M Dekkers ◽  
Eleonora P M Corssmit ◽  
Johannes A Romijn

ObjectiveThe aim of this study was to perform a systematic review and meta-analysis on insulin resistance in adult patients with type 1 diabetes mellitus compared to healthy controls, assessed by hyperinsulinemic euglycemic clamp studies.Design and methodsWe conducted a systematic search of publications using PubMed, EMBASE, Web of Science and COCHRANE Library. Hyperinsulinemic euglycemic clamp studies comparing adult patients with type 1 diabetes mellitus to healthy controls were eligible. Primary outcome measures were pooled mean differences of insulin sensitivity of endogenous glucose production (EGP), of glucose uptake and of lipolysis. We estimated mean (standardized) differences and 95% CIs using random effects meta-analysis.ResultsWe included 38 publications in this meta-analysis. The weighed mean differences in EGP during hyperinsulinemia between patients and controls was 0.88 (95% CI: 0.47, 1.29) in the basal state and 0.52 (95% CI: 0.09, 0.95) in insulin stimulated conditions, indicating decreased hepatic insulin sensitivity in patients. Insulin sensitivity of glucose uptake was either reported as M value (M), glucose infusion rate (GIR), glucose disposal rate (GDR) or metabolic clearance rate (MCR). Weighed mean differences were similar for M −3.98 (95% CI: −4.68, −3.29) and GIR −4.61 (95% CI: −5.86, −3.53). Weighed mean difference for GDR was −2.43 (95% CI: −3.03, −1.83) and −3.29 (95% CI: −5.37, −1.22) for MCR, indicating decreased peripheral insulin sensitivity in patients. Insulin mediated inhibition of lipolysis was decreased in patients, reflected by increased non-esterified fatty acid levels.ConclusionsInsulin resistance is a prominent feature of patients with type 1 diabetes mellitus and involves hepatic, peripheral and adipose tissues.


Sign in / Sign up

Export Citation Format

Share Document